PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A309. A total of 32 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $493,551 | +54.8% | 244,332 | -0.1% | 0.01% | +80.0% |
| Q4 2022 | $318,828 | +24.5% | 244,482 | +0.1% | 0.01% | 0.0% |
| Q3 2022 | $256,000 | -3.0% | 244,332 | 0.0% | 0.01% | 0.0% |
| Q2 2022 | $264,000 | +2.7% | 244,332 | 0.0% | 0.01% | +25.0% |
| Q1 2022 | $257,000 | -20.9% | 244,332 | 0.0% | 0.00% | -20.0% |
| Q3 2021 | $325,000 | -65.2% | 244,332 | -50.0% | 0.01% | -58.3% |
| Q2 2021 | $934,000 | – | 488,664 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 2,413,487 | $2,513,000 | 0.04% |
| CAPITAL PERFORMANCE ADVISORS LLP | 25,974 | $27,000 | 0.02% |
| MEITAV INVESTMENT HOUSE LTD | 244,332 | $256,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 133,790 | $139,000 | 0.00% |
| IHT Wealth Management, LLC | 22,000 | $23,000 | 0.00% |
| Psagot Value Holdings Ltd. / (Israel) | 6,000 | $6,000 | 0.00% |
| Smith Salley Wealth Management | 12,048 | $13,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 3,027 | $3,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| DAVENPORT & Co LLC | 22,000 | $23,000 | 0.00% |